Humanized antibodies against leukocyte adhesion molecule VLA-4
US5840299A · kind A · utility
156Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 1995 |
| Grant date | Nov 24, 1998 |
| Priority date | — |
| Expiry date | Nov 21, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for treatment of multiple sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.